Skip to content

Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women

Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06145009
Enrollment
51
Registered
2023-11-22
Start date
2023-10-30
Completion date
2025-10-10
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet, Healthy, Eating Behavior, Nutrition, Healthy, Time Restricted Eating

Brief summary

The purpose of this study is to assess how time restricted eating interventions impact eating behaviors, diet quality, and body composition in women ages 20-29 years. Participants will be asked to limit all food and drinks (except water and some non-caloric beverages) to a 10-hour period during the day for four weeks. Participants 1-36 will follow their usual eating and activity patterns for one week before starting, and follow whatever eating pattern they want for 4 weeks after finishing. Participants 37-51 will follow their usual eating and activity patterns for one week before starting, and will not complete a follow up period.

Interventions

BEHAVIORALTime restricted eating

Limit food intake to 10 hours per day as described in the experimental arm section.

Sponsors

University of Delaware
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Able to speak and read English * Own a smartphone * BMI ≥ 20 kg/m2 * Usual eating window ≥ 12 hours with the last eating occasion after 8pm on the majority of days * Have at least a moderate baseline level of dietary restraint

Exclusion criteria

* Shift workers * Being pregnant, nursing, or planning to become pregnant in the next 6 months * Having a past or current eating disorder diagnosis * Having a chronic medical condition (including diabetes, heart, kidney, or thyroid disease) or a condition that requires therapeutic diet or specified meal timing

Design outcomes

Primary

MeasureTime frameDescription
Emotional EatingParticipants 1-36: 3 time points: baseline, end of 4-week intervention, end of 4-week follow up Participants 37-51: 2 time points: baseline, end of 4-week interventionDutch Eating Behavior Questionnaire: Emotional Eating Subscale. This subscale is scored from 1-5, with higher scores indicating higher emotional eating.
External EatingParticipants 1-36: 3 time points: baseline, end of 4-week intervention, end of 4-week follow up Participants 37-51: 2 time points: baseline, end of 4-week interventionDutch Eating Behavior Questionnaire: External Eating Subscale. This subscale is scored from 1-5, with higher scores indicating higher external eating.
Eating in the Absence of HungerParticipants 1-36: Baseline week, weeks 1 and 4 of intervention, weeks 1 and 4 of follow up Participants 37-51: Baseline week, weeks 1 and 4 of interventionAssessed through surveys sent 5x/day asking about if food was eaten and why.

Secondary

MeasureTime frameDescription
Diet QualityParticipants 1-36: 3 time points: baseline, end of 4-week intervention, end of 4-week follow up Participants 37-51: 2 time points: baseline, end of 4-week interventionHealthy Eating Index, calculated from 3-day food records. The Healthy Eating Index is scored from 0-100, with higher scores indicating higher diet quality.
Body composition (total percent body fat)Baseline and end of 4-week intervention (participants 1-36 only)Percent body fat measured by DXA
Body composition (visceral fat)Baseline and end of 4-week intervention (participants 1-36 only)Visceral fat measured by DXA
Body weightParticipants 1-36: 3 time points: baseline, end of 4-week intervention, end of 4-week follow up Participants 37-51: 2 time points: baseline, end of 4-week interventionTotal body weight
Continuous Glucose MonitoringFirst 10 days of study, last 7 days of intervention period (added for participants 37-51, optional for participants 29-36)Participants will wear a Dexcom continuous glucose monitor

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCarly Pacanowski, PhD

University of Delaware

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026